NL8303211A - Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. - Google Patents

Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. Download PDF

Info

Publication number
NL8303211A
NL8303211A NL8303211A NL8303211A NL8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A NL 8303211 A NL8303211 A NL 8303211A
Authority
NL
Netherlands
Prior art keywords
cisplatinum
sterile
lyophilized
product
stable
Prior art date
Application number
NL8303211A
Other languages
English (en)
Dutch (nl)
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NL8303211A publication Critical patent/NL8303211A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8303211A 1982-09-23 1983-09-16 Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan. NL8303211A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2339682 1982-09-23
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento

Publications (1)

Publication Number Publication Date
NL8303211A true NL8303211A (nl) 1984-04-16

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8303211A NL8303211A (nl) 1982-09-23 1983-09-16 Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan.

Country Status (20)

Country Link
US (1) US4670262A (xx)
JP (1) JPS5978117A (xx)
AT (1) AT382077B (xx)
AU (1) AU559499B2 (xx)
BE (1) BE897761A (xx)
CA (1) CA1211372A (xx)
CH (1) CH655852A5 (xx)
DE (1) DE3333024A1 (xx)
DK (1) DK157168C (xx)
FI (1) FI78236C (xx)
FR (1) FR2533439B1 (xx)
GB (1) GB2127291B (xx)
GR (1) GR79055B (xx)
IE (1) IE56173B1 (xx)
IL (1) IL69752A (xx)
IT (1) IT1153974B (xx)
NL (1) NL8303211A (xx)
SE (1) SE464061B (xx)
SU (1) SU1424722A3 (xx)
ZA (1) ZA836904B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
DK500185A (da) * 1984-11-02 1986-05-03 Johnson Matthey Plc Oploeseliggjort platinforbindelse
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
CA2122342A1 (en) * 1992-09-04 1994-03-17 Hironori Kawabata Pharmaceutical composition
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
NZ518847A (en) * 1999-11-15 2004-02-27 Pharma Mar S Aplidine treatment of cancers
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
US7507766B2 (en) * 2000-10-12 2009-03-24 Pharma Mar, S.A. Treatment of cancers
FI2251344T4 (fi) 2001-01-25 2024-04-29 The United States Of America Represented By The Secretary Boronihappoyhdisteiden formulointi
CA2461187C (en) * 2001-09-21 2010-06-22 Sumitomo Pharmaceuticals Co., Ltd. Lyophilized formulation
EP1435991B1 (en) * 2001-10-19 2008-10-15 Pharma Mar, S.A. Use of aplidine for the treatment of pancreatic cancer
PL1603584T3 (pl) * 2003-03-12 2009-02-27 Dana Farber Cancer Inst Inc Aplidyna do leczenia szpiczaka mnogiego
EP1620117A4 (en) * 2003-03-12 2009-07-29 Pharma Mar Sa IMPROVED ANTITUMORAL TREATMENTS
ATE347367T1 (de) * 2003-10-13 2006-12-15 Zoser B Salama Pharmazeutische zusammensetzung umfassend oxoplatin und dessen salze
US8436190B2 (en) 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
EP2029155B1 (en) * 2006-02-28 2016-04-13 Pharma Mar S.A. Improved treatment of multiple myeloma
EP2205263A1 (en) * 2007-10-19 2010-07-14 Pharma Mar, S.A. Improved antitumoral treatments
MX2010009697A (es) * 2008-03-07 2010-09-30 Pharm Mar S A Tratamientos anticancerigenos mejorados.
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
CA2735899A1 (en) 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
CA1119954A (en) * 1978-05-30 1982-03-16 Edmund S. Granatek Aqueous solution of cisplatin
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
AU541056B2 (en) * 1980-03-31 1984-12-13 Bristol-Myers Company Pharmaceuticals formulations

Also Published As

Publication number Publication date
FI78236B (fi) 1989-03-31
SU1424722A3 (ru) 1988-09-15
IL69752A0 (en) 1983-12-30
DE3333024A1 (de) 1984-03-29
DK424383A (da) 1984-03-24
CH655852A5 (de) 1986-05-30
GB8324380D0 (en) 1983-10-12
IE56173B1 (en) 1991-05-08
BE897761A (fr) 1984-01-02
IT8223396A0 (it) 1982-09-23
IT1153974B (it) 1987-01-21
IE832172L (en) 1984-03-23
SE8304920L (sv) 1984-03-24
FI78236C (fi) 1989-07-10
SE464061B (sv) 1991-03-04
FR2533439B1 (fr) 1986-08-14
GB2127291A (en) 1984-04-11
FI833300A0 (fi) 1983-09-15
GB2127291B (en) 1986-01-15
SE8304920D0 (sv) 1983-09-13
FI833300A (fi) 1984-03-24
DK157168C (da) 1990-04-09
DK157168B (da) 1989-11-20
FR2533439A1 (fr) 1984-03-30
DK424383D0 (da) 1983-09-16
ZA836904B (en) 1984-10-31
AT382077B (de) 1987-01-12
AU1908983A (en) 1984-03-29
JPS5978117A (ja) 1984-05-04
CA1211372A (en) 1986-09-16
US4670262A (en) 1987-06-02
GR79055B (xx) 1984-10-02
IL69752A (en) 1986-07-31
ATA326283A (de) 1986-06-15
AU559499B2 (en) 1987-03-12

Similar Documents

Publication Publication Date Title
NL8303211A (nl) Nieuwe farmaceutische preparaten op basis van cisplatinum en werkwijze voor het bereiden daarvan.
JPH0313174B2 (xx)
CZ298581B6 (cs) Farmaceuticky stabilní prípravek oxaliplatiny k parenterální aplikaci
EP2887953B1 (en) Improved daptomycin injectable formulation
RU2362557C2 (ru) Фармацевтическая композиция винфлунина, предназначенная для парентерального введения, способ получения и применение
CN101991857B (zh) 稳定型药物制剂及其制备方法
JPS6360008B2 (xx)
JPS60215631A (ja) インタ−ロイキン−２組成物
US20120065151A1 (en) Substances Mixture, Use and Infusion Solution
JPS5938207B2 (ja) 腎疾患治療剤
JPS61197527A (ja) インタ−ロイキン−２組成物
CN1074278C (zh) 前列腺素e1无菌冻干粉针剂生产工艺
RU2096043C1 (ru) Антигипоксическое средство и способ его получения
RU2680804C1 (ru) Стабильное средство лечения болезней суставов
KR20070067768A (ko) 안정한 옥살리플라틴 조성물 및 이의 제조방법
RU2504376C1 (ru) Высокостабильный фармацевтический состав на основе лиофилизата производных 3-оксипиридинов, или метилпиридинов, или их фармацевтически приемлемых солей
JP2770571B2 (ja) 安定化された注射剤および注射剤の安定化法
EP1691813B1 (en) Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one, sterile, stable; closed system for packing the solution, process for eliminating alkaline residuals of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one crystals;
KR950010149B1 (ko) 5-클로로-1-[1-{3-(2,3-디하이드로-2-옥소-1h-벤즈이미다졸-1-열)프로필}-4-피페리딘]-1,3-디하이드로-2h-벤즈이미다졸-2-온(돔페리돈) 액제의 제조방법
JP6172880B1 (ja) ダルベポエチンを含む液体医薬組成物
RU2199321C1 (ru) Смесевая лекарственная форма на основе фторпиримидинового антиметаболита и способ ее получения
JP6033931B2 (ja) 有機溶媒無含有ゲムシタビン水溶液組成物
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
WO2005020876A2 (en) Pharmaceutical composition, method of manufacturing and therapeutic use thereof
RU97119749A (ru) Способ лечения рака мочевого пузыря

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: ERBAMONT INDUSTRIALE S.R.L.

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: ERBA S.R.L. FARMITALIA CARLO -

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed